News

Demand for Dutch diagnostic SMEs curves with corona

Jessica Vermeer
Reading time: 3 minutes

With the increasing market demand, the corona crisis caused Micronit to ramp up production. This was challenging, because of the disrupted supply chain. However, Micronit CEO Ronny van ’t Oever also sees the opportunities this crisis offers for innovative Dutch medical SMEs like his.

One of the early goals in fighting a disease like COVID-19 is to map the virus and its family. This can be done by determining its specific DNA sequence. “If you know the DNA, or in this case, RNA sequence, you can effectively develop the necessary PCR reagents,” explains CEO Ronny van ’t Oever. Polymerase chain reaction (PCR) is a method used in molecular biology to make billions of copies of a DNA sample, which are then used to identify infectious agents.

Enschede-based Micronit is the producer of chips that allow specialists to determine the DNA or RNA sequence of viruses. Sparked by the spread of the corona pandemic, the company’s products have seen an enormous increase in demand. “Within a few weeks, our entire safety stock ran out,” depicts van ’t Oever. Seeing his team’s response, however, gave him a great sense of pride as an entrepreneur. “At times like these, my team shows an admirable passion and drive.”

This article is exclusively available to premium members of Bits&Chips. Already a premium member? Please log in. Not yet a premium member? Become one for only €15 and enjoy all the benefits.

Login

Related content